Medical management of primary hyperparathyroidism.

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Primary hyperparathyroidism (PHPT) involves parathyroid gland hyperfunction and excessive parathyroid hormone (PTH) secretion.
• Management options include parathyroidectomy (PTX) or non-surgical medical therapy.
• Medical therapy is suitable for asymptomatic PHPT patients who are unwilling or unable to undergo surgery.

Purpose of the Study:

• To review non-surgical management strategies for PHPT.
• To highlight pharmacological treatments for PHPT.
• To discuss perioperative management considerations.

Main Methods:

• Literature review focusing on non-surgical PHPT treatments.
• Emphasis on bisphosphonates, denosumab, cinacalcet, and hormone therapy.
• Inclusion of combined therapy and perioperative management aspects.

Main Results:

• Bisphosphonates, denosumab, cinacalcet, and hormone therapy are key pharmacological agents.
• Combined therapies offer potential treatment benefits.
• Perioperative management is crucial for surgical candidates.

Conclusions:

• Non-surgical medical therapy provides an alternative for specific PHPT patient groups.
• Pharmacological agents like bisphosphonates, denosumab, and cinacalcet are effective.
• Comprehensive management includes consideration of both surgical and non-surgical approaches.